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Abstract. Understanding Mycobacterium tuberculosis biodiversity and transmission is significant for tuberculosis
control. This short report aimed to determine the genetic diversity of M. tuberculosis isolates from an outpatient clinic
in Panama City. A total of 62 M. tuberculosis isolates were genotyped by 12 loci mycobacterial interspersed repetitive
units-variable number of tandem repeats (MIRU-VNTR) and Spoligotyping. Forty-five (72.6%) of the isolates showed
unique MIRU-VNTR genotypes, and 13 (21%) of the isolates were grouped into four clusters. Four isolates showed
polyclonal MIRU-VNTR genotypes. The MIRU-VNTR Hunter-Gaston discriminatory index reached 0.988. The
Spoligotyping analysis revealed 16 M. tuberculosis families, including Latin American-Mediterranean, Harlem, and
Beijing. These findings suggest a wide genetic diversity of M. tuberculosis isolates at one outpatient clinic. A detailed
molecular epidemiology survey is now warranted, especially following second massive immigration for local Panama
Canal expansion activities.
Tuberculosis (TB) affects nearly 8.7 million people world-
wide.1 In 2011, most TB cases were reported in Asia (59%) and
Africa (26%), although cases were reported to a lesser extent
in the Eastern Mediterranean Region (7.7%), the European
Region (4.3%), and the Americas Region (3%). Panama
stands as the country with the highest TB mortality rate in
Central America.2 In 2012, more than 1,500 TB cases were
reported in Panama, for an average incidence rate of 43.1 cases
per 100,000 inhabitants.3 Areas located at the Pacific and
Atlantic entries of the Panama Canal have harbored the
highest numbers of TB cases since the Canal’s construction.4
Despite sanitation improvements in terminal port cities, recent
studies have revealed elevated TB transmission as a result of
a high clustering rate among multidrug-resistant TB cases.5,6
However, data on the transmission of drug-susceptible TB
within the general population remain scarce and have not been
updated to reflect a second wave of immigration connected
with Panama Canal expansion activities.7
Mycobacterium tuberculosis genotyping has proven to be the
most important laboratory tool in understanding TB trans-
mission.8 In addition to studies on patient contacts; information
on molecular epidemiology is useful for evaluating TB control
program results. Genotyping also assists in monitoring molecu-
lar markers associated with virulence, immunogenicity, and
drug resistance9; among the genotyping tools available, the
IS6110-restriction fragment length polymorphism (RFLP) ref-
erence standard method is based on the number of repetitions
of the IS6110 sequence along the M. tuberculosis genome.10
This tool discriminates between clonally related and unrelated
isolates. On the other hand, Spoligotyping focuses on detecting
43 spacer sequences in the direct repeat region of theM. tuber-
culosis genome. Unfortunately, the IS6110–RFLP method is a
complex and laborious procedure, whereas Spoligotyping is
faster and simpler but less discriminating.11,12 The study of
mycobacterial interspersed repetitive units-variable number of
tandem repeats (MIRU-VNTR) is an alternative to genotyping
M. tuberculosis isolates.13,14 Our study aimed to characterize
the genetic diversity of M. tuberculosis isolates in one out-
patient clinic using a combination of 12 loci MIRU-VNTR.
A total of 62 clinical isolates were collected at the Social
Security Clinical Laboratory of the Complejo Hospitalario
Metropolitano Dr. Arnulfo Arias Madrid between January
and December of 2005. The strain collection was performed as
part of the Panamanian standard of patient care for TB diag-
nosis and control in Panama City. These isolates accounted for
16.3% of all pulmonary TB cases reported in Panama City
in 2005. The DNA extraction was performed using a method
described previously.10 A total of 12 MIRU-VNTR loci were
amplified according to a modified protocol described by
Cowan and colleagues.13 The amplification products were ana-
lyzed by electrophoresis on an agarose gel. The number of
MIRU-VNTR alleles was determined according to the sizes
proposed by Cowan and colleagues, which allocate the number
of alleles by the fragment size.13 The allelic diversity for each
MIRU-VNTR was calculated using the number of alleles at
each locus.15 The ability to detect the number of allelic repeti-
tions of each allele for every MIRU-VNTR was then classified
as high, moderate, or low.We used the Hunter-Gaston discrim-
inatory index (HGDI) to determine the discriminating power
of possessing all 12 MIRU -VNTR loci in our study.16 Spoligo-
typing was performed on genomic DNA using the standard
method described by Kamerbeek and colleagues.17 The family
label and Spoligotype octal code numbers were obtained from
the SPOLDB4.0.18
Our findings show high genetic diversity of M. tuberculosis
clinical isolates obtained from outpatients from a clinic in
Panama City. Our results reveal that a total of 45 (72.5%)
M. tuberculosis isolates showed unique MIRU-VNTR pat-
terns (Table 1). Moreover, a total of 13 (20%) isolates were
grouped into four clusters. Cluster A (225326-133323) included
six isolates, and three isolates were grouped into cluster B
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(224326-153321). The other two clusters were composed of
two M. tuberculosis isolates each: cluster C (223325-153324)
and cluster D (123237-253227). Four (6.4%) isolates showed
only two alleles simultaneously. The presence of two alleles
may suggest infection with two or moreM. tuberculosis strains
in these patients. Alternatively, the presence of these strains
could be a result of triploid polyclones, similar to that reported
for Mycobacterium bovis Bacillus Calmette Gue´rin.19 These
findings indicate the genetic diversity of M. tuberculosis circu-
lating in patients with drug-susceptible pulmonary TB in an
outpatient clinic in Panama City. Further detailed studies are
needed to determine the connection between patients with
isolates in the same clusters.
The 12 MIRU-VNTR loci we used showed high discrimina-
tory power forM. tuberculosis clinical isolates from the studied
outpatient clinic. The discriminatory power of each MIRU
facilitated allelic diversity assessment. In our study, the
MIRU-VNTR 10, 23, 26, 31, and 40 were highly discriminating.
The MIRU 16, 20, and 24 showed low discriminatory power.
Thus, our 12 MIRU-VNTR loci showed high discriminatory
power, similar to previous reports using this marker set.14,20
This allelic diversity allowed us to reach an HGDI of 0.988.
Thus, we confirmed the discriminatory power of this set of
12 MIRU-VNTR loci for analyzing M. tuberculosis isolate
samples in Panama City. This feature will be useful in tracking
outbreak episodes, relapses, or cross-contamination of M.
tuberculosis in community-based studies.21–23 In contrast, the
Spoligotyping analysis identified 93% of the clinical M. tuber-
culosis isolates (Table 2). We identified 16 M. tuberculosis
family Spoligotypes including Latin American-Mediterranean,
Harlem, and Beijing. Only four (7%) of the M. tuberculosis
clinical isolates were not annotated in the SPOLDB4.0 database.
The wide genetic diversity of drug-susceptibleM. tuberculosis
clinical isolates collected from a single outpatient clinic is
a limited reflection of population dynamics throughout the
Panamanian Isthmus. During the early 20th century, the
Panama Canal construction attracted a worldwide workforce,
especially laborers from the Caribbean and Europe. As a result,
Panama and Colon Cities comprised a wide variety of ethnic
backgrounds that possibly harbored various M. tuberculosis
genotypes. The high diversity of M. tuberculosis strains from a
single outpatient clinic in our study is one example of this
hypothesis. A similar effect of migration on M. tuberculosis
diversity has been shown in other cosmopolitan cities in the
Americas.24,25 These studies have associated the great genetic
diversity of M. tuberculosis clinical isolates with the mixture of
city inhabitants. A century later, Panama is currently expanding
the Panama Canal and attracting a new labor force that could
introduce new M. tuberculosis strains.7 Detailed surveillance
studies using larger data sets are urgently required to monitor
and understand the spread ofM. tuberculosis amongPanamanian
and immigrant TB case contacts. Such studies would help
improve TB control measures to decrease the mortality rate.
Prompt genotyping of clinical isolates using state-of-the-art
polymerase chain reaction-based tools, such as 24-MIRU-
VNTR and Spoligotyping, should be implemented to deter-
mine epidemiological relationships and infections with two or
more M. tuberculosis strains.26,27 Such a strategy would allow
the identification of genotypes that are sustaining the disease
burden and provoking death. This approach would also deter-
mine if there is any specific M. tuberculosis subpopulations
related to higher TB transmission within the country.
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Table 1
MIRU-VNTR genotypes for M. tuberculosis clinical isolates with a
unique genotype recovered from an outpatient clinic in Panama City
(2005)*
Isolate MIRU-VNTR Isolate MIRU-VNTR Isolate MIRU-VNTR
1 224325153323 16 224325153221 31 223326153321
2 226425153322 17 224325143324 32 223325173533
3 226226153323 18 224325143324 33 223325153323
4 225335253323 19 224322153323 34 223236253323
5 225335233322 20 224315143324 35 225325153324
6 225326133324 21 224315143323 36 224335253323
7 225325153321 22 224216252321 37 224325153322
8 225325153123 23 223526143322 38 225326133323
9 225325143323 24 223425143324 39 124326154326
10 225325143321 25 223335253324 40 123336253222
11 225226163321 26 223335253321 41 123326153326
12 224425173533 27 223326253321 42 123326163326
13 224336253323 28 223326153321 43 224325153323
14 224335253323 29 223326153321 44 123326153326
15 224326133313 30 223326153321 45 223326153321
*MIRU-VNTR = mycobacterial interspersed repetitive units-variable number of
tandem repeats.
Table 2
Spoligotype family genotypes of M. tuberculosis clinical isolates
recovered from an outpatient clinic in Panama City (2005)
Octal Spoligotyping code n (%) ofM. tuberculosis isolates Family label
777777777760731 7 (13.0) T2
776177400000171 6 (11.1) U (LAM3?)
777777777720771 6 (11.1) H3
777777607760771 5 (9.3) LAM9
000076777760671 3 (5.6) LAM5
704003347760471 3 (5.6) T4_CEU1
777777777760771 3 (5.6) T1
000000000003771 2 (3.7) BEIJING
776177607760771 2 (3.7) LAM3
777736776000071 2 (3.7) unknown
777777743760771 2 (3.7) LAM10_CAM
000000007560771 1 (1.9) T1
466177400000171 1 (1.9) unknown
476177400000171 1 (1.9) unknown
777677607760771 1 (1.9) LAM9
777736777760771 1 (1.9) X1
777767777760731 1 (1.9) T1
777776777760601 1 (1.9) X2
777777477400001 1 (1.9) U
777777764020771 1 (1.9) H1
777777770000000 1 (1.9) U (likely H)
777777770000171 1 (1.9) unknown
777777774020731 1 (1.9) H1
777777774020771 1 (1.9) H1
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